11 Fibrillar deposits of α-Synuclein (αS) are the hallmark of Parkinson's disease. Recent evidence 12
Introduction 22
The pathologies of Parkinson's disease (PD) and related synucleinopathies are 23 characterized by the accumulation of aggregates of the neuronal protein α-Synuclein (αS) 24 (Goedert, 2001) . The prevailing hypothesis is that toxicity is mediated by prefibrillar oligomers of 25 αS. Emerging evidence suggests that cell-to-cell transmission of toxic αS species underlies disease 26 progression (Guo and Lee, 2014) , although molecular details of this process, including the identity 27 of relevant extracellular inter-action partners, are lacking. 28
αS is a small, soluble protein that is intrinsically disordered in the cytoplasm (Theillet et 29 al., 2016) . It binds peripherally to anionic lipid bilayers through its N-terminal domain, which 30 becomes α-helical upon binding (Dikiy and Eliezer, 2014) . The localization of αS to nerve 31 terminals (George et al., 1995 , Diao et al., 2013 and to cellular lipid raft domains (Fortin et al., EndoH-treated SH-SY5Y GPMVs by FCS, as in Figure 1C . Binding +/-PNGaseF from Figure 1C shown for 74 comparison. The data are presented as mean±SD, n=3. Scale bars=20 µm.
76
The following figure supplement is available for Intramolecular FRET measurements were made of αS labeled at residues 9 and 72, 81 encompassing much of membrane-binding domain of αS. Mean energy transfer efficiencies (ETeff) 82 of αS bound to SH-SY5Y GPMVs, without and with PNGaseF treatment, are 0.43±0.08 and 83 0.19±0.06, respectively ( Figure 2 ). This lower ETeff is comparable to that of the elongated helix 84 previously observed by single molecule FRET for αS upon binding to synthetic lipid bilayers 85 (Trexler and Rhoades, 2009) . αS assumes multiple conformations on even simple synthetic lipid 86 vesicles (Robotta et al., 2011) ; the relatively broad FRET distributions observed here may reflect 87 a similar degree of conformational heterogeneity. In the absence of complex N-linked glycans, αS 88 binds to GPMVs through interactions with the lipid bilayer resulting in a predominantly extended 89 conformation. In the presence of N-linked glycans, αS binding is enhanced and requires a 90 conformation distinct from the extended, membrane-bound α-helix. 
131
The following figure supplement is available for 
134
To identify whether αS binding to glycans requires either the associated glycoproteins or a 135 lipid bilayer, binding of αS to glycans in solution was measured by fluorescence correlation 136 spectroscopy (FCS). SH-SY5Y cells were treated with each of the three endoglycosidases above, 137 and the cleaved carbohydrates were isolated. The carbohydrates were titrated into αS-AL488 and 138 the autocorrelation curves were fit to extract the diffusion time and average number of fluorescent 
186
The following figure supplement is available for Figure 4 : All αS constructs used in this work were checked by MALDI to confirm correct mass and presence 253 of acetylation (Figure supplement 7) . 254
For NMR measurements, 15N-labeled αS was grown in E. coli BL21 stocks containing the 255 NatB plasmid in minimal medium (6 g/L Na2HPO4.7H2O, 3 g/L KH2PO4, 0.5 g/L NaCl, 1mM 256
MgS04, 300 µM CaCl2, 0.5 g/L 15 NH4Cl) instead of LB medium and purified as described above. For dual fluorophore labeling for FRET measurements, cysteines were introduced at 269 residues 9 and 72. The protein was labeled as described above, with the following modifications. 270
The protein was first incubated with donor fluorophore AL488 maleimide at a ratio of protein:dye 271 of 1:0.5 for 2 h at room temperature with stirring. Then, a 4x molar excess of acceptor fluorophore 272 AL594 maleimide (Invitrogen) was added, and the reaction was continued overnight at 4 °C. The 273 labeled protein was separated from unreacted dye as described above. αS labeled at these positions 274 have been extensively studied in our lab; as documented in our previous publications, they do not GPMV buffer (10 mM HEPES, 150 mM NaCl, 2 mM CaCl2, pH 7.4) twice and then exposed to 324 25 mM formaldehyde and 2 mM DTT for 2 h to induce blebbing. To reduce the content of DTT, 325
GPMVs were dialyzed in GPMV buffer prior to use in experiments. GPMVs were also created 326 using N-ethylmaleimide as the blebbing reagent, with comparable results. The phospholipid 327 content of final material was measured by total phosphate assay. 328 Phosphate assay. Lipid concentrations for GPMV preparations were estimated by measuring total 329 phosphate, assuming that all measured phosphate is from phospholipids, and that all lipids are 330 phospholipids. This is a practical assumption designed to ensure reproducibility. To ensure that PNGaseF is removed from GPMVs or cells after incubation (and therefore 352 does not remain associated with either, blocking potential αS binding sites), we compared the 353 amount of PNGaseF added to either GPMVs or cells with that removed after incubation. PNGaseF 354 (5,000 units/ml) containing a chitin domain was added to chambers containing either GPMVs or 355 cells and incubated at 37°C for 6 h, as for the experiments described above. After incubation, the 356 buffer or media containing PNGaseF was removed incubated with chitin magnetic beads to isolate 357 and concentrate the enzyme. Blank chambers containing only PNGaseF in buffer or media were 358 subjected to the same treatment. 20 uL of each sample was run on a 4-12% polyacrylamide gels 359 and stained with Coomassie blue. Gels were imaged using a Typhoon FLA7000 gel imager (GE 360 Life Sciences) using Coomassie stain mode. The gels indicate that essentially all of the enzyme is 361 removed (Figure supplement 8) . 362
Quantification of carbohydrates. Concentrations of carbohydrates isolated from GPMVs or cells 363
were quantified by using the Total Carbohydrate Quantification Assay Kit (Abcam, MA, USA) 364 following the manufacturer's instructions. Briefly, the carbohydrates are first hydrolyzed to 365 monomer sugar units and then converted to furfural or hydrofurfural. These compounds are 366 converted to chromogens, which can be detected by absorbance at 490 nm. Glucose was used to 367 generate a standard curve for calculated of the total carbohydrate concentration of the samples. Image acquisition and processing were performed with the software accompanying the 402 FV3000 microscope and Image J software (Schneider et al., 2012) . For SH-SY5Y cells, 403
internalized αS was quantified either by analysis of the punctate structures in the cells or by the 404 total cellular fluorescence; for primary neurons, internalized αS was quantified by total cellular 405 fluorescence. For total cellular fluorescence, the integrated fluorescence intensity of the cells is 406 calculated and reported. Cellular puncta were analyzed using the Image J particle analysis plug-407 in. This algorithm detects puncta through a user-defined threshold and counts the number of puncta 408 that meet or exceed the threshold. The threshold was initially defined by manual identification and 409 averaging of a subset of puncta. Colocalization with lysosomes was computed by obtaining a 410
Pearson coeffieient using the ImageJ plugin for co-localization (Coloc_2). 
where τDA and τD and are the donor excited state lifetime in the presence and absence of acceptor. 440
Six FLIM images were recorded for each of three biological repeats per condition. The histograms 441 shown in Figure 2 represents ETeff values for selected pixels from equatorial sections of the 442 GPMVs as indicated on the images to their left. The histograms were fit with a Gaussian function 443 to extract the mean ETeff. 444
Images were obtained in 8-well NUNC chambers (Thermo Scientific, Rochester, NY, 445 USA) coated with Poly-D-lysine, containing 250 µl of GMPV at 5 µM phospholipid concentration 446 and 80 nM of αS labeled with Alexa 488. For all experiments using these chambers, the chambers 447 were passivated by polylysine-conjugated PEG treatment to prevent any nonspecific absorption to 448 the chamber surfaces (Middleton and Rhoades, 2010) . 449
Fluorescence correlation spectroscopy (FCS). Fluorescence correlation spectroscopy (FCS) 450 measurements were carried out on a lab-built instrument, as described previously (Trexler and 451 Rhoades, 2009) . A 488-nm-wavelength laser was adjusted to 5 µW prior to entering the 452 microscope. Fluorescence emission was collected through the objective and separated from laser GPMVs and uptake by cells. FCS measurements were made on the instrument described above. 473
For GPMV binding, experiments were performed in 8-well NUNC chambers (Thermo Scientific, 474
Rochester, NY, USA) containing 250 µl of GMPV at 5 µM phospholipid concentration. The laser 475 focal volume was located to a height of 100 µm from the bottom surface of the wells, above all 476
GMPVs. αS labeled with Alexa 488 (80 nM) was added to wells with GPMVs and the 477 autocorrelation measurements were taken immediately and after 60 minutes. Each curve was 478 integrated for 30 s, repeated 10 times and data was analyzed as described above. and cultured for 48 h prior to measurements. Control wells contained the same volume of media 486 without cells; these control for non-specific adsorption of protein to the well surfaces. αS-AL488 487 (200 nM) was added to the wells at the start of the experiment, and the autocorrelation curves were 488 taken in the medium well above the cells, at a height of 100 µm from the bottom surface of the 489 wells. The curves were collected at regular intervals, over a period ranging from 2 to 24 h, and 490 each autocorrelation curve integrated for 30 s, repeated 10 times. Data were analyzed as described 491 above. Cellular uptake was assessed by measuring the change in the number of molecules of 492 fluorescently labeled αS present in the media surrounding the cells relative to the starting 493 concentration. In between measurements, the chambers were returned to the incubators to maintain 494 the temperature in the wells at 37°C. As a negative control for both the GPMV binding and cell 495 uptake studies, GPMVs or cells were incubated with 80 nM eGFP. There was no evidence of eGFP 496 binding to the GPMVs nor of internalization by SH-SY5Y cells (Figure supplement 10) . 497 Cellular uptake by PAGE. As an orthogonal approach to the FCS and imaging approached 498 described above, uptake of both monomer and PFF αS were quantified by PAGE. SH-SY5Y cells 499
were incubated with 200 nM αS, as described above for FCS uptake experiments. After incubation 500 for the desired time (1, 3, 5, 8, 12, or 24 h) the media was removed from cells and stored at 4°C. 501
After all samples were collected, 20 µl of each sample were run on a 4-12% polyacrylamide gel. 502
To quantify the amount of protein internalized, an identical set of experiments was carried 503 out, with modifications as described in the following. For each time point, transferrin-AL488 (100 504 nM) was added 30 min prior to the due time of the time point to serve as a loading control. At the 505 desired time points, the cells were detached from the wells by 0.05% Trypsin-EDTA (Life 506 Technologies), pelleted and lysed in 250 µl RIPA lysis buffer (Thermo Fisher). Cell lysates (20 µl 507 of stock) were run on PAGE gels. Cell lysates (20 µl) were run on 4-12% polyacrylamide gels. 508
Gels of both extracellular and internalized αS were imaged using a Typhoon FLA7000 gel 509 imager (GE Life Sciences) using fluorescent imaging mode to detect αS-AL488 or transferrin-510 AL488. Image J was used to quantify the bands. 511
Statistical analysis. Data are expressed as the mean ± SD, and were examined by a one-way 512 analysis of variance (n = 3). More than three experiments were performed and similar results were 513 obtained. P values less than 0.05 were considered to be significant. filling, apodization and baseline correction were applied. 1 H chemical shifts were referenced using 531 water resonance and 15 N chemical shifts were referenced indirectly based on gyromagnetic ratios 532 of respective nuclei. Previously assigned αS backbone resonances were used (Kang et al., 2011) . 533
Binding to the PNGaseF derived glycans results in non-uniform peak intensity increases 534 throughout the sequence of αS. For analysis, 10 peaks showing large increases and 10 peaks 535
showing small or no increases were selected to roughly cover the entire sequence. The same 536 residues were used for each analyzed dataset. For each set of peaks, the relative magnitude of 537 increase (as compared to αS in solution without glycans) expressed as a percentage was calculated 538 and averaged. A difference between two numbers is reported in Figure 3C of the manuscript. The 539 same calculation was carried out for the mono-and tri-saccharides, which do not bind to αS, shown 540
in Figure supplement 2E . 541 542
